Vai al contenuto
Global sound
AI For Pharma Growth

AI For Pharma Growth

E232: The Early Readout: Upgrading the Interim Analysis to Catch Futility and Success Years Sooner

· 28 min · Episodio 232

Note dell’episodio

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Tom Coates, CEO of Presentient, about why interim analysis in clinical trials is ready for a major upgrade.
Interim analyses allow sponsors to look at trial data mid-flight and assess whether a study is likely to succeed or fail, using pre-specified rules. But Tom explains that many phase two and three commercial trials still do not include a pre-planned interim analysis, meaning sponsors often wait far longer than necessary to detect futility or act on early signs of success.
The conversation explores how Presentient is…

Sito web: podcasters.spotify.com

In diretta, ultima ora: 4.880 brani su 1.615 stazioni in 105 paesi

Scopri il mondo attraverso la radio

Altri modi per scoprire (7)

Hai sentito qualcosa di bello? Salvalo, o aprilo subito in Spotify.

★ Artista della settimana Il brano che sale più in fretta in radio questa settimana
Il tuo brano qui? Da € 9 a settimana →
3R Radio Roessli RapperswilContinua ad ascoltare